Shandong Wit Dyne Health Co.,Ltd. (000915.SZ)
ValueMarkers Composite Index
59% below intrinsic value ($10)
Shandong Wit Dyne Health Co.,Ltd. (000915.SZ) — VMCI valuation read
Shandong Wit Dyne Health Co.,Ltd. (000915.SZ) carries a VMCI composite of 67/100, 17 points above the Healthcare sector median of 50. Among mid-cap names, that gap places 000915.SZ in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).
The 000915.SZ insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.
**Investor frame.** Value reads 000915.SZ trades at 24.0x earnings, 33% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 0.1x leaves covenant headroom, the line to track on Shandong Wit Dyne Health Co.,Ltd.'s next 10-Q.
000915.SZ rose 2.0% over the trailing 7 days, with a +1.2% read on a 30-day basis.
Shandong Wit Dyne Health Co., Ltd. engages in the research, development, and production of children healthcare and medicine products. Its products include vitamin A and D drops, compound calcium carbonate effervescent granules, licorice zinc granules, iron dextran granules, pediatric ibuprofen suppositories, azithromycin granules, dimercaptosuccinic acid capsules, rifaximin dry suspension, and oral rehydration salt powder. The company was founded on June 26, 1993 and is headquartered in Jinan, China.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.